Tandem Diabetes Care Inc
TNDM· Nasdaq
Released Mar 1, 2018, after the close
10-K filed Mar 1, 2018, 60 days after period end · 0001564590-18-004141
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $40.29M | $28.91M | $29.12M | $17.89M |
| Net Income | -$11.41M | -$14.82M | -$12.09M | -$18.47M |
| EPS Diluted |
Tandem Diabetes Care Inc · CIK 1438133 · Engraved from SEC EDGAR
| -$1.23 |
| -$4.80 |
| -$0.40 |
| -$0.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.